menu
    • menu

    Company profile for Veradermics

    NEW Drugs in Dev: 3
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Veradermics is a pioneering biotechnology company dedicated to advancing dermatology through innovative treatments. With a robust pipeline of five novel product candidates, Veradermics addresses large-market conditions such as androgenetic alopecia (pattern hair loss), common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis. Our mission is to bring transformative therapies to adults and children, focusing o...
    Veradermics is a pioneering biotechnology company dedicated to advancing dermatology through innovative treatments. With a robust pipeline of five novel product candidates, Veradermics addresses large-market conditions such as androgenetic alopecia (pattern hair loss), common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis. Our mission is to bring transformative therapies to adults and children, focusing on conditions that have long been underserved by existing treatment options. Driven by science and patient needs, Veradermics aims to redefine dermatological care with safe, effective, and accessible solutions.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    VeradermicsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    470 James St New Haven, CT 06513
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.veradermics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Veradermics Tests Oral Rogaine for Hair Growth in First Trial
    Veradermics Tests Oral Rogaine for Hair Growth in First Trial

    27 Apr 2026

    // ENDPOINTS

    https://endpoints.news/veradermics-wins-at-growing-hair-with-oral-rogaine-in-first-key-test-as-a-public-company/

    ENDPOINTS
    27 Apr 2026
    Share Share
    Veradermics' VDPHL01 Drives Hair Growth in Phase 2/3 Trial
    Veradermics' VDPHL01 Drives Hair Growth in Phase 2/3 Trial

    27 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260427832356/en/Veradermics-Oral-VDPHL01-Achieved-Early-Consistent-and-Robust-Hair-Growth-in-Positive-Phase-23-302-Clinical-Trial-in-Male-Pattern-Hair-Loss

    BUSINESSWIRE
    27 Apr 2026
    Share Share
    Veradermics Announces Launch of Public Offering
    Veradermics Announces Launch of Public Offering

    27 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260427216066/en/Veradermics-Announces-Launch-of-Public-Offering

    BUSINESSWIRE
    27 Apr 2026
    Share Share
    Veradermics Reports Q4 and Full Year 2025 Financial Results
    Veradermics Reports Q4 and Full Year 2025 Financial Results

    30 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260330204835/en/Veradermics-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Highlights-Recent-Corporate-and-Clinical-Updates

    BUSINESSWIRE
    30 Mar 2026
    Share Share
    Veradermics Showcases VDPHL01, Patient Experiences at 2026 AAD
    Veradermics Showcases VDPHL01, Patient Experiences at 2026 AAD

    18 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260318655567/en/Veradermics-Announces-Presentations-on-VDPHL01-and-Patient-Experiences-With-Pattern-Hair-Loss-at-2026-American-Academy-of-Dermatology-Annual-Meeting

    BUSSINESSWIRE
    18 Mar 2026
    Share Share
    Veradermics To Participate In Upcoming March Investor Conferences
    Veradermics To Participate In Upcoming March Investor Conferences

    03 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260303202376/en/Veradermics-to-Participate-in-Upcoming-March-Investor-Conferences

    BUSINESSWIRE
    03 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search